
Sign up to save your podcasts
Or


Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope!
Join us as Dr. Eric Padron of Moffitt Cancer Center and Dr. Lee Greenberger of The Leukemia & Lymphoma Society unveil the groundbreaking new CMML Initiative, fueled by recent funding aimed at revolutionizing treatment. Discover how this initiative is paving the way for individualized therapies that promise to enhance the quality of life for CMML patients and bring us closer to a cure.
Mentioned on this episode:
Additional LLS Support Resources:
Support for this episode is provided by Taiho Oncology, Inc.
The post Advancing the Science: Chronic Myelomonocytic Leukemia (CMML) first appeared on The Bloodline with Blood Cancer United Podcast.
By Blood Cancer United4.9
4646 ratings
Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope!
Join us as Dr. Eric Padron of Moffitt Cancer Center and Dr. Lee Greenberger of The Leukemia & Lymphoma Society unveil the groundbreaking new CMML Initiative, fueled by recent funding aimed at revolutionizing treatment. Discover how this initiative is paving the way for individualized therapies that promise to enhance the quality of life for CMML patients and bring us closer to a cure.
Mentioned on this episode:
Additional LLS Support Resources:
Support for this episode is provided by Taiho Oncology, Inc.
The post Advancing the Science: Chronic Myelomonocytic Leukemia (CMML) first appeared on The Bloodline with Blood Cancer United Podcast.

25,922 Listeners

14,603 Listeners

37,446 Listeners

12,155 Listeners

87,964 Listeners

113,432 Listeners

208 Listeners

5,094 Listeners

12 Listeners

4,860 Listeners

14,434 Listeners

6,583 Listeners

8,205 Listeners

6,472 Listeners

41,574 Listeners